UBS Maintains a 'Buy' on CVS Caremark (CVS); Frustrations Remain, But Cheap Here
Tweet Send to a Friend
UBS maintains a 'Buy' on CVS Caremark (NYSE: CVS), lowers PT from $46 to $42.
UBS analyst says, "While EPS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst says, "While EPS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
